Results of this analysis show that, compared to B lymphocytes as a control, the NHL subtypes Burkitt’s lymphoma, DLBCL, and FL show a trend towards higher expression of BCL-xL, while, on the other hand, multiple myeloma and CLL show an expression similar to the control. This evidence concerns the gene BCL2L1 and diffuse large B-cell lymphoma.